March 2015

E-transactions could save providers, plans $8B per year ()
FDA approves investigational study for new smaller SynCardia Total Artificial Heart ()
Limb function, sensation not impinged by radial artery access ()
FDA clears CoreValve for valve-in-valve treatment ()
Graphic shortcomings: EHRs display lab test data poorly ()
Benefit of percutaneous heart pumps murky despite skyrocketing use ()
Following STEMI PCI, discharge after 48 hours as safe as 3 to 4 days ()
Heart failure disease management model does not outshine usual care ()
First fully-implantable micropacemaker designed for fetal use ()
Hospital volumes influence ECMO outcomes in adults ()
AHA calls for changes to Hospital Readmission Reduction Program ()
Another opportunity with the SGR ()
Stroke risk may be high for some patients with heart failure but no a-fib ()
House votes to repeal SGR; Senate’s next ()
Elevated postop BUN level may predict stroke likelihood ()
SCAI keynotes to emphasize tech, big data and research needs ()
ACC.15: Upcoming PCI AUC take into account past criticisms ()
Hep C therapy may interact with amiodarone ()
The C-suite spot: More physicians step in as hospital leaders ()
Pharmacist-physician teams improve patients' blood pressure control ()
AMC Health and Qualcomm collaborate to enhance connectivity and virtual care coordination for chronic care patients ()
NIH selects awardees to help speed development of health technologies ()
Nearly a decade apart, husband and wife get lifesaving heart implant to prevent strokes ()
Poor showing for intracranial stent vs. medical therapy … again ()
TAVR market may top $3B by 2020 ()
FDA targets GE, Siemens MRIs in Class II recalls ()
Guidelines outline criteria for transcatheter pulmonic valve replacement ()
It’s Not Our Founding Fathers’ Cath Lab ()
FDA clears Impella heart pump to assist in high-risk PCIs ()
Watchman prevails at last, getting FDA's OK ()
Taking a 5,000-mile ride for stroke prevention ()
ACC.15: Turning TAVR’s growth into hospital profits ()
Adulthood plaque risks increased in children with parents who smoked ()
When no statin is best: Reassessing meds at end of life ()
Janssen ventures into antithrombin antibody-based drugs ()
Beyond playtime: Gamer-inspired health app expanding ()
FDA OKs pacemaker that allows for MRI scans ()
ACC.15: Focusing big data on patients fosters better preventive care ()
FDA adds Protégé to list of approved iliac stents ()
Tapping into today's tech: When patients record doctor visits ()
Sequoia Hospital and Cleveland Clinic form affiliation to bring exceptional and unmatched cardiac care to the peninsula ()
From interactive (ACC) to inactive (SGR) ()
Patients often confuse acute MI, other conditions in self-reports ()
TOTAL: Opening eyes but not shutting doors ()
MRI beats echo for accuracy of mitral regurgitation assessment ()
ACC.15: TOTAL provides clarity for interventional cardiologists ()
ACC.15: TAVR safe and effective in low-risk patients, with caveats ()
ACC.15: Talking Twitter with cardiologists about power of social media ()
Heart, imaging groups join 700 societies in SGR plea ()
FDA recalls sheaths used for caths ()
FDA approves 2nd generation subcutaneous ICD ()
American College of Cardiology elects Dr. Kim Allan Williams president ()
ACC.15: Weight loss improves afib symptoms but fluctuation worsens them ()
ACC.15: Ablation with mitral valve surgery proves safe, effective ()
Everolimus-eluting stent outcomes roll snake eyes in registry analysis ()
ACC.15: How 3 trials inform adult congenital heart disease practices ()
New CHAMPION data show significant improvement in survival rates for heart failure patients with reduced ejection fraction ()
Medtronic CoreValve Evolut R System yields exceptional outcomes in first clinical study ()
New analysis from investigational IMPROVE-IT study shows VYTORIN (ezetimibe/simvastatin) reduced total (initial and recurrent) cardiovascular events more than Simvastatin alone in patients presenting with acute coronary syndromes ()
SAPIEN 3 Valve demonstrates low mortality, excellent 30-day outcomes in high- and intermediate-risk patients ()
ACC.15: TOTAL raises flag over use of routine thrombectomy ()
Findings to be presented at Annual Scientific Session of the American College of Cardiology (ACC) about an additional potential reversal strategy for and real-world safety performance of XARELTO ()
Stealth BioTherapeutics announces EMBRACE results: A phase 2 clinical study of Bendavia in acute coronary syndrome ()
Favorable late-breaking clinical trial data from initial commercial use presented on transcatheter mitral valve repair system at ACC 2015 ()
NeoStem announces PreSERVE AMI clinical trial one-year follow-up results ()
SCCT statement on the PROMISE clinical trial ("A Randomized Comparison of Anatomic versus Functional Diagnostic Testing Strategies in Symptomatic Patients with Suspected Coronary Artery Disease"), presented at the ACC Scientific Sessions ()
Medtronic to initiate clinical study of drug-filled stent following successful preclinical results ()
ACC.15: PCSK9 inhibitor appears to improve outcomes ()
Medtronic to initiate clinical study of drug-filled stent following successful preclinical results ()
Sanofi and Regeneron announce 18-month results of ODYSSEY LONG TERM Trial with Praluent (alirocumab) published in The New England Journal of Medicine ()
ACC.15: PARTNER I outcomes equal for TAVR, surgery at 5 years ()
ACC.15: CoreValve’s advantage over surgery widens at 2 years ()
ACC.15: Do less testing & DAPT’s OK among trial takeaways ()
ACC.15: CTA holds slight edge despite a draw on outcomes ()
ACC.15: Ticagrelor stays course of low long-term MI, death, stroke rates ()
ACC.15: Get to know GE Healthcare ()
ACC.15: Get to know Philips Healthcare ()
ACC.15: Get to know Medtronic ()
Quantum conferencing ()
MI risk message isn’t getting through between patients and providers ()
7 innovative technologies you'll want to see at ACC.15 ()
11K volunteer to join app-based heart study ()
In terms of public reporting, clinical trials less than results-oriented ()
Agfa HealthCare enhances Enterprise Imaging Suite with launch of integrated ECG Management System at ACC.15 ()
Medtronic initiates pivotal studies of Resolute Onyx drug-eluting stent in United States ()
Cholesterol disorder offers clues about statins and diabetes ()
Benefit of restrictive transfusions with coronary surgery put in doubt ()
Caregivers of destination LVAD patients benefit from support, too ()
Agfa HealthCare launches Enterprise Imaging for Cardiology at ACC.15 ()
Sanofi and Regeneron to present new data from investigational agent Praluent™ (alirocumab) phase 3 program at ACC.15 ()
The Cost & Reimbursement Disconnect ()
Direct Deposit: PAD Stents & Balloons Deliver Drugs Where They Count ()
Keeping Claims-free Tips for Avoiding Liability Suits ()
Managers, the Link Between EHRs & Effectiveness ()
A Stroke of Genius: Gains Seen on Many Fronts at Meeting ()
Structured Reporting: Harnessing Data in the Cath Lab ()
EVARREST Fibrin Sealant Patch a potential solution for aortic reconstruction surgery ()
ICD Threshold Testing: Time to Give Practice a Jolt? ()
Breathing Easy Using Extubation in the OR ()
Cath Lab Inventory Management: Improving the Bottom Line ()
No Symptoms, No Screening? CCTA Still May Find Niche in Diabetes Care ()
EHRs: Heartache & Helpmate for Cardiologists ()
Modern treatment strategies change outlook for adults with hypertrophic cardiomyopathy from grim to good ()
Culprit or complete? Primary PCI findings add to ongoing stenting debate ()
TAVR death rate rises to 23.7 percent at 1 year in registry analysis ()
Inpatient access to EHRs: Fears allayed but benefits don’t pan out ()
Apple’s ResearchKit pumps new blood into heart studies ()
Cleveland Clinic names Lars Svensson, M.D., Ph.D, chairman of its Heart & Vascular Institute ()
Sunshine Heart suspends trial after reports of deaths ()
In isolation, AUCs for diagnostic caths may miss mark ()
AliveCor launches new app that automatically tells patients when their ECG recording is normal ()
Coronary CT angiography may outperform functional imaging ()
FDA approves two-device CPR system ()
Centers venture into same-day discharge after ICD placement ()
During device surgery, warfarin wins over heparin for cost-effectiveness ()
An ACC highlight & why it matters ()
10 sessions you can’t miss at ACC.15 ()
Bioresorbable scaffolds, drug-eluting stents equal at 9-month follow-up ()
Harnessing technology innovations to improve cardiovascular health outcomes ()
Statin use increases risk of type 2 diabetes by 46% ()
Pay change favors outpatient atherectomies, but not Medicare ()
HEART tool reduces cardiac testing in patients with acute chest pain ()
Moderate coffee consumption may stave off atherosclerosis ()
Hospitals take selective approach with CMS bundled payments ()
ACC guideline app upgrade includes full set of prevention guidelines ()
Taking aim at clinic shootings: Should hospitals take the lead? ()
Quality measure may cause unintended harms ()
2014 guidelines greatly expand oral anticoagulation’s ranks ()
115 blood tests per heart patient: In-hospital draws draining them dry ()
Cardinal Health makes $2B bid for Cordis ()
Poor response to statins may signal progression in blocked arteries ()
Truven’s top 100 hospitals: Here’s who made the cut for 2015 ()
Scripps opens most advanced heart care institute on the West Coast ()
St. Jude sets aside $15M to settle Riata cases ()